Note 18. Income Taxes

U.S. and international components of income (loss) before income taxes is as follows:

Year Ended December 31, 

(Thousands)

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

U.S.

$

(99,309)

$

(77,808)

$

(34,695)

International

2,191

1,430

(6,130)

Loss before income taxes and equity in earnings from unconsolidated entities

$

(97,118)

$

(76,378)

$

(40,825)

Income tax expense (benefit) consisted of the following:

Year Ended December 31, 

(Thousands)

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

Current expense (benefit)

Federal

$

$

$

State

451

447

266

Foreign

889

(6)

(112)

Total current

1,340

441

154

Deferred expense (benefit)

Federal

(792)

1,244

(7,365)

State

(219)

(27)

236

Foreign

(2,077)

2,070

617

Total deferred

(3,088)

3,287

(6,512)

Income tax expense (benefit)

$

(1,748)

$

3,728

$

(6,358)

A reconciliation of income tax expense (benefit) to the federal statutory rate is as follows:

Year Ended December 31, 

2025

2024

2023

(Thousands)

Amount

Rate

Amount

Rate

Amount

Rate

U.S. federal statutory tax rate

  ​ ​ ​

$

(19,361)

  ​ ​ ​

21.0%

  ​ ​ ​

$

(16,039)

  ​ ​ ​

21.0%

  ​ ​ ​

$

(8,573)

  ​ ​ ​

21.0%

State and local income taxes, net of federal income tax effect1

103

(0.1)%

326

(0.4)%

447

(1.1)%

Foreign tax effects

United Kingdom

Change in valuation allowance

(1,965)

2.1%

617

(0.8)%

677

(1.7)%

Other

54

(0.1)%

367

(0.5)%

96

(0.2)%

Rwanda

Change in valuation allowance

(2,341)

2.5%

567

(0.7)%

829

(2.0)%

Other

2,425

(2.6)%

(53)

0.1%

(249)

0.6%

Other foreign jurisdictions

181

(0.2)%

267

(0.3)%

441

(1.1)%

Effect of cross-border tax laws

Global intangible low-taxed income ("GILTI") inclusion

1,400

(1.5)%

1,021

(1.3)%

—%

Change in valuation allowance

17,193

(18.6)%

17,366

(22.7)%

1,771

(4.3)%

Nontaxable or nondeductible items

—%

Change in fair value of warrants

—%

(1,473)

1.9%

(2,144)

5.3%

Excess compensation (§162(m))

1,730

(1.9)%

70

(0.1)%

717

(1.8)%

Share-based payment awards

947

(1.0)%

390

(0.5)%

(838)

2.1%

Other nontaxable or nondeductible items

194

(0.2)%

268

(0.4)%

152

(0.4)%

Other adjustments

Basis difference in equity method investment

(2,572)

2.8%

—%

—%

Other

264

(0.3)%

34

(0.0)%

316

(0.8)%

Income tax expense (benefit)

$

(1,748)

1.9%

$

3,728

(4.9)%

$

(6,358)

15.6%

1 - State taxes in California made up the majority (greater than 50 percent) of the tax effect in this category in both 2025 and 2023, while state taxes in Virginia and Illinois made up the majority in 2024.

Income taxes paid, net of refunds, by jurisdiction consisted of the following:

(Thousands)

  ​ ​ ​

December 31, 2025

  ​ ​ ​

December 31, 2024

  ​ ​ ​

December 31, 2023

Federal

$

$

$

State

436

411

487

Foreign

United Kingdom

622

905

Other foreign jurisdictions

108

40

Total

$

1,166

$

411

$

1,432

The Company paid income taxes, net of refunds of $1.2 million, $0.4 million and $1.4 million for years ended December 31, 2025, 2024 and 2023, respectively. For the years ended December 31, 2025 and 2023, the Company paid income taxes, net of refunds in the United Kingdom of $0.6 million and $0.9 million respectively. As the remaining amounts of income taxes paid, net of refunds are considered immaterial to the consolidated financial statements, further disaggregation by federal, state and foreign jurisdictions has not been provided.

Deferred income tax assets and liabilities were recognized on temporary differences between the financial and tax basis of existing assets and liabilities as follows:

(Thousands)

  ​ ​ ​

December 31, 2025

  ​ ​ ​

December 31, 2024

Deferred tax assets

Liabilities and reserves

$

2,978

$

2,058

Interest limitation

26,550

20,633

Net operating losses

72,087

65,630

Transaction expenses

143

165

Inventories

1,445

Stock compensation

1,891

1,753

Derivatives

1,972

Operating lease liabilities

15,246

15,709

Other

2,269

1,438

Total

124,581

107,386

Valuation allowance

(55,762)

(30,542)

Total deferred tax assets, net

$

68,819

$

76,844

Deferred tax liabilities

Property, plant and equipment

$

(39,450)

$

(42,659)

Intangible assets

(24,442)

(25,061)

Derivatives

(7,071)

Right-of-use assets

(14,550)

(15,267)

Inventories

(1,278)

Other

(537)

(462)

Total

(78,979)

(91,798)

Net deferred tax liability

$

(10,160)

$

(14,954)

We establish a valuation allowance to reduce deferred tax assets if, based on the weight of the available evidence, both positive and negative, for each respective tax jurisdiction, it is more likely than not that some portion or all of the deferred tax assets will not be realized. A valuation allowance related to domestic deferred tax assets of $54.2 million was recorded as of December 31, 2025, of which $44.0 million and $8.9 million were against the Company’s federal and state net operating loss carryforwards, respectively, and $1.1 million was against an equity method investment. A valuation allowance related to domestic deferred tax assets of $26.7 million was recorded as of December 31, 2024, of which $21.0 million and $5.7 million were against the Company’s federal and state net operating loss carryforwards, respectively. A valuation allowance related to foreign deferred tax assets of $1.6 million and $3.8 million was recorded against certain foreign net operating losses as of December 31, 2025 and 2024, respectively. The amount of deferred tax assets considered realizable could be adjusted in the near term, resulting in an increase to the valuation allowance, if estimates of future taxable income during the carryforward period are reduced.

Activity in the valuation allowance is as follows:

(Thousands)

  ​ ​ ​

December 31, 2025

  ​ ​ ​

December 31, 2024

  ​ ​ ​

December 31, 2023

Beginning balance

$

30,542

$

12,878

$

8,464

Additions

25,220

17,664

4,414

Ending Balance

$

55,762

$

30,542

$

12,878

During the year ended December 31, 2025, the valuation allowance increased $25.2 million, which was comprised of additional income tax expense of $16.3 million that is reflected as a component of the effective tax rate against continuing operations, and $6.9 million reflected as a component of other comprehensive income.

As of December 31, 2025, the Company had federal net operating loss carryforwards of approximately $319.0 million which do not expire. As of December 31, 2025, the Company had post-apportionment state net operating loss carryforwards of approximately $220.2 million which begin to expire in 2030. As of December 31, 2025, the Company had foreign net operating loss carryforwards of approximately $6.6 million which begin to expire in 2030.

As of December 31, 2025 and 2024, the Company’s reserve for uncertain tax positions was $6.7 million and $5.0 million, respectively. Of the total reserve for uncertain tax positions as of December 31, 2025 and 2024, only $0.1 million and $0.1 million, respectively, would impact the effective tax rate if released. As indicated in Note 3, the Company re-revaluates uncertain tax positions on a quarterly basis. The Company recognizes potential interest and penalties relating to unrecognized tax positions as a component of income tax expense (benefit). A reconciliation of the beginning and ending balances of the reserve for uncertain tax positions is as follows:

(Thousands)

  ​ ​ ​

December 31, 2025

  ​ ​ ​

December 31, 2024

  ​ ​ ​

December 31, 2023

Beginning balance

$

4,999

$

3,990

$

96

Additions for tax positions in prior period

2,473

Additions for tax positions in current period

1,704

1,009

1,421

Ending Balance

$

6,703

$

4,999

$

3,990

As of December 31, 2025, undistributed earnings of certain foreign subsidiaries are intended to be permanently reinvested outside the U.S. Accordingly, no provision for foreign withholding tax, foreign exchange gains/losses or state income taxes associated with a distribution of these earnings has been made. The amount of the unrecognized deferred tax liability on these unremitted earnings is not material.

We are subject to taxation in the United States and various states and foreign jurisdictions, including the United Kingdom. As of December 31, 2025, we have no tax years under examination by the IRS, and there are currently no state or foreign income tax examinations in process. The Company is subject to United States federal income tax examinations for years after 2020 and to state and foreign income tax examinations for years after 2020.

Historical Timeline

Fiscal YearFiled
2025Mar 10, 2026Showing above
2024Mar 12, 2025
2023Mar 15, 2024
2022Mar 21, 2023

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.